Early clinical trial results from Gilead show that its antiviral drug, remdesivir, has promise in treating patients with severe COVID-19. Though there are major caveats, there is good reason for cautious optimism.
Why are basic questions about the biology of SARS-CoV-2 so hard to answer?
Dr. Derek Lowe, arguably the finest and most influential chemistry blogger in the universe, has put together an excellent summary of the complex and confusing clinical data of hydroxychloroquine, which he published recently in his blog in Science and Translational Medicine. We thank Derek and AAAS for allowing us to reprint this important article.
The world anxiously awaits while clinical trials of remdesivir are in progress. The drug failed to stop Ebola. Does this mean it will also fail to stop coronavirus? No. According to a new study in the Journal of Biological Chemistry, the drug should work better. Here's why.
A South Korean company named Seoul Semiconductor claims to have developed an ultraviolet light-emitting diode (UV LED) that can kill 99.9% of SARS-CoV-2 in 30 seconds.
If or when the economy collapses -- and especially if the virus keeps spreading anyway -- public sentiment will change quickly and drastically. Americans' trust in the medical establishment may be shaken. Like ventilators, the national supply of goodwill isn't unlimited.
"Test here. Test now. Test, baby, test!" has become the conventional wisdom for handling the COVID-19 pandemic. But false positives and false negatives create substantial problems for mass testing.
No, the novel coronavirus that causes COVID-19 is not a biological weapon. But that doesn't mean the virus didn't escape from a laboratory. A growing body of circumstantial evidence indicates that very well may be what happened.
Different countries may appear to have different death rates, but only because they have applied different sampling and reporting policies to their accounting efforts. It's not necessarily because they are managing the virus any better, or that the virus has infected fewer, or more, people.
The biology of the virus will help us learn how to fight it.
How well we do in assessing the economic outcomes of the COVID-19 lockdown will determine how well we do in the next match. And there will be a next match.
Q: Where do you go to find overpaid, under-sane professors, talking about chemistry when they know nothing about it? A: MIT, the home of Dr. Stephanie Seneff, who has spent a career making up nonsense about glyphosate. And she's outdone herself this time: Glyphosate causes COVID. Nope, not kidding.